Showing results (1-10 of 233) with videos related to
Sort By:
Pageof 24
Clinical and Experimental Immunology|December 12, 2001
Distribution of lymphocytes of the alpha(E)beta(7) phenotype and E-cadherin in normal human urothelium and bladder carcinomasJ Cresswell, H Robertson, D E Neal, et al.British Journal of Urology|November 1, 1995
P53 and ploidy assessed by flow cytometry in bladder washingsT R Griffiths, J K Mellon, G A Pyle, et al.British Journal of Cancer|July 2, 1998
Alterations of TP53 in microdissected transitional cell carcinoma of the human urinary bladder: high frequency of TP53 accumulation in the absence of detected mutations is associated with poor prognosisR Abdel-Fattah, C Challen, T R Griffiths, et al.Clinical and Experimental Immunology|April 21, 1999
Bladder cancer immunogenicity: expression of CD80 and CD86 is insufficient to allow primary CD4+ T cell activation in vitroS J Pettit, S Ali, E O'Flaherty, et al.International Journal of Radiation Oncology, Biology, Physics|December 1, 2001
Combined p21WAF1/CIP1 and p53 overexpression predict improved survival in muscle-invasive bladder cancer treated by radical radiotherapyK N Qureshi, T R Griffiths, M C Robinson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
TP53 accumulation predicts improved survival in patients resistant to systemic cisplatin-based chemotherapy for muscle-invasive bladder cancerK N Qureshi, T R Griffiths, M C Robinson, et al.Current Opinion in Urology|October 13, 2006
Treatment of chronic prostatitis: an etiologicaly based approachD E NealBritish Medical Journal (Clinical Research Ed.)|June 8, 1985
Complications of ileal conduit diversion in adults with cancer followed up for at least five yearsD E NealPageof 24